Johns Hopkins Malaria Research Institute

What Johns Hopkins Malaria Research Institute does

The Johns Hopkins Malaria Research Institute (JHMRI) is a nonprofit academic research institute within the Johns Hopkins Bloomberg School of Public Health, founded in May 2001 with an initial gift from Bloomberg Philanthropies. It conducts discovery research at a state-of-the-art facility in Baltimore, Maryland (615 N. Wolfe Street, E5141) and field research at the Macha Research Trust in Zambia, with additional research sites across sub-Saharan Africa, India, and other endemic regions. The institute's scientific mission centers on treating and controlling malaria, developing vaccines, identifying new drug targets, and creating innovative prevention and cure strategies — with particular attention to emerging threats such as drug-resistant parasites.

JHMRI operates with 33 full-time faculty and has no commercial revenue model. It is funded continuously by Bloomberg Philanthropies and supported by 130+ pilot grants awarded for capacity building in endemic regions. Its core deliverables are research outputs, not products: 750+ first- and last-authored publications since 2010, open-access scientific findings, training programs, and knowledge dissemination through podcasts, newsletters, videos, and social media. The institute is led by Director Jane Carlton, PhD, with senior researchers including William Moss, MD, and David Sullivan, MD, who are regularly cited as authoritative voices in outlets such as Nature, The Guardian Nigeria, and Yahoo! Travel.

The institute serves the global public health community — governments, NGOs, healthcare providers, and research institutions working on malaria elimination — rather than commercial customers. Its go-to-market motion is community-led: scientific expertise is shared through open-access publications, media engagements, training programs, and pilot grants, with no pricing, licensing, or sales infrastructure.

Name

Johns Hopkins Malaria Research Institute

Legal name

Johns Hopkins Malaria Research Institute

Website

https://malaria.jhsph.edu

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

1–10 employees

Short description

The Johns Hopkins Malaria Research Institute is a nonprofit academic research institute within the Johns Hopkins Bloomberg School of Public Health, founded in 2001 and funded by Bloomberg Philanthropies. It conducts malaria discovery research in Baltimore and field research in endemic regions including Zambia, sub-Saharan Africa, and India, serving the global public health community.

Ownership category

akta.pro rank

Product category

Academic Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE)

akta.pro secondary industries

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

• Malaria research
• Vaccine development
• Drug target discovery
• Field epidemiology
• Public health research

Headquarters

HQ city

Baltimore

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Philanthropic Funding: The institute is funded through Bloomberg Philanthropies, which has provided continuous support since its founding in May 2001. The initial gift established a state-of-the-art research facility. No commercial revenue model applies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

The Johns Hopkins Malaria Research Institute is an academic research institute within the Johns Hopkins Bloomberg School of Public Health that conducts malaria discovery research in Baltimore and field research at the Macha Research Trust in Zambia and other endemic sites in sub-Saharan Africa, India, and elsewhere. Its work focuses on treating and controlling malaria, developing vaccines, identifying new drug targets, and devising innovative prevention and cure strategies, supported continuously by Bloomberg Philanthropies since its founding in May 2001.

Product overview

The Johns Hopkins Malaria Research Institute is an academic research institute focused on malaria elimination efforts. It conducts discovery research at the Bloomberg School of Public Health in Baltimore and field research at the Macha Research Trust in Zambia, with additional research sites in sub-Saharan Africa, India, and elsewhere. The institute's primary offerings are research programs, training programs, publications, podcasts, and newsletters aimed at treating and controlling malaria, developing vaccines, and finding new drug targets and innovative strategies to prevent and cure malaria.

Differentiator

Problem solved

Functional benefit

Products and services

• Malaria Discovery Research Program
• Field Research at Macha Research Trust
• Training and Pilot Grant Programs

Quantifiable outcome

• 130+ pilot grants awarded supporting research capacity building
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Macha Research TrustcoreStrategic or Co-development PartnerThe institute conducts field research at the Macha Research Trust in Zambia, one of the key sites for endemic malaria research in sub-Saharan Africa. This partnership enables bridging of laboratory discoveries with real-world field applications.

Scale indicators5 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Centers for Disease Control and Prevention - Malaria Branch: The CDC's malaria program leads U.S. malaria surveillance, prevention, and research efforts. It is comparable to JHMRI as both work on malaria prevention, treatment guidance, and vaccine/therapeutic research, though CDC operates as a broader public health agency.

Emerging players

• Broad Institute Infectious Disease Program: The Broad Institute applies genomics and systems biology to infectious disease, including malaria parasite biology and drug resistance. It is comparable to JHMRI as both drive malaria drug target and parasite biology research, though Broad emphasizes genomic-scale approaches.

Direct peers

• London School of Hygiene & Tropical Medicine: LSHTM conducts large-scale malaria and tropical disease research, including field epidemiology and clinical trials across endemic regions. It is comparable to JHMRI as both are leading academic research centers focused on malaria science with global field footprints.
• Liverpool School of Tropical Medicine: LSTM is a globally recognized malaria and tropical medicine research institution with strong field research programs. It is comparable to JHMRI as both are academic institutes combining laboratory discovery with endemic-region field research on malaria.
• PATH Malaria Vaccine Initiative: PATH drives malaria vaccine development and access globally. It is comparable to JHMRI as both are malaria-specific initiatives working on vaccine R&D, drug targets, and prevention strategies across endemic regions.
• Innovative Vector Control Consortium (IVCC): IVCC develops and tests novel vector control tools to combat malaria transmission. It is comparable to JHMRI as both focus on innovative malaria prevention strategies, including mosquito-related research relevant to transmission control.
• Medicines for Malaria Venture (MMV): MMV is a product development partnership focused on discovering, developing, and delivering new antimalarial drugs. It is directly comparable to JHMRI as both organizations target malaria treatment and control with overlapping focus on drug targets and innovative therapies.
• Walter Reed Army Institute of Research: WRAIR runs one of the world's largest military malaria research programs, including vaccine and drug development. It is comparable to JHMRI as both conduct malaria vaccine R&D, drug target identification, and operate field research in endemic regions.

Regional players

• Ifakara Health Institute: Ifakara is a leading African health research institute conducting malaria and vector-borne disease research in Tanzania. It is comparable to JHMRI as both operate field research in sub-Saharan Africa and contribute to malaria epidemiology and control evidence.

Others

• World Health Organization Global Malaria Programme: WHO's GMP sets global malaria policy, treatment guidelines, and elimination targets. It is comparable to JHMRI as a coordinating authority whose priorities shape demand for malaria research and policy translation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/JHMRImalaria
• YouTubeyoutube.com/channel/UC6mMWcHOqRaDZSFB64EZW0A
• Facebookfacebook.com/JHMRI
• LinkedInlinkedin.com/company/johns-hopkins-malaria-research-institute
• Instagraminstagram.com/jhmalaria

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Johns Hopkins Malaria Research Institute